ELFA kits fall within ELISA exemption; extended limitation and penal consequences fail in bona fide classification dispute.

ELFA diagnostic kits were held to fall within the ELISA-based exemption under Notification No. 50/2017-Cus. and the corresponding IGST notification because both kits operated on the same underlying immunological principle, and the difference was only in signal detection mode. The exemption entry was read in light of technical literature, expert clarifications and the beneficial object of the notification, so denial of concessional duty and IGST was unsustainable. The extended period under Section 28(4) of the Customs Act was also found unsustainable because the dispute was a bona fide classification and exemption issue without wilful suppression or intent to evade duty, and the related demand, confiscation, redemption fine and penalties accordingly fell away.

---

---

Issues: (i) Whether ELFA diagnostic kits are covered by the exemption available to ELISA kits under Notification No. 50/2017-Cus. and the corresponding IGST notification; and (ii) whether invocation of the extended period under Section 28(4) of the Customs Act, 1962 and the consequential demand, confiscation, redemption fine and penalties were sustainable.

Issue (i): Whether ELFA diagnostic kits are covered by the exemption available to ELISA kits under Notification No. 50/2017-Cus. and the corresponding IGST notification.

Analysis: The imported kits were found to operate on the same underlying immunological principle as ELISA, namely antigen-antibody interaction with enzyme-linked detection. The difference between ELISA and ELFA was held to lie only in the terminal mode of signal detection, colourimetric in one case and fluorescence-based in the other, not in the essential scientific principle. The Court placed weight on technical literature, the clarification issued by the National Institute of Biologicals and CDSCO stating that ELISA and ELFA are one and the same, earlier departmental practice extending similar benefit to identical goods, and the settled principle that exemption entries concerning scientific and medical products must be read in light of technological progression and their beneficial object.

Conclusion: ELFA kits were held to fall within the scope of the ELISA-based exemption, and the denial of concessional duty and IGST was unsustainable.

Issue (ii): Whether invocation of the extended period under Section 28(4) of the Customs Act, 1962 and the consequential demand, confiscation, redemption fine and penalties were sustainable.

Analysis: The dispute was held to be one of classification and eligibility to exemption on facts that were fully within the Department's knowledge, and not a case of proven wilful suppression or deliberate misstatement. The Court found that the description in the bills of entry did not establish an intent to evade duty in the face of a bona fide interpretative dispute supported by expert clarifications. Once the exemption claim was accepted, the foundation for confiscation, redemption fine, penalty, and the related duty and interest demand also fell away.

Conclusion: Invocation of the extended period and the connected demand and penal consequences were held to be unsustainable.

Final Conclusion: The impugned order was set aside, and the importer obtained full relief on merits as well as on limitation and penal consequences.

Ratio Decidendi: Where a diagnostic product remains scientifically rooted in the same underlying assay principle, technological refinement in the mode of detection does not by itself take the product outside an exemption entry referring to the broader assay category; and in the absence of wilful suppression or intent to evade duty, the extended limitation period and related penal consequences cannot be invoked.

---